We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and patients.

These findings suggest that Lrp5-related bone diseases might originate from signals ... as glucagon-like peptide-2 and serotonin act in an endocrine fashion to suppress bone turnover 2.

When there is a disruption in this system, it can lead to endocrine disease. Get expert information on the types, symptoms, and treatments of endocrine disease.

LONDON, UK I March 17, 2025 I High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary ...